These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8417204)

  • 21. Pseudomonas exotoxin A: from virulence factor to anti-cancer agent.
    Wolf P; Elsässer-Beile U
    Int J Med Microbiol; 2009 Mar; 299(3):161-76. PubMed ID: 18948059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant immunotoxins: new therapeutic agents for cancer treatment.
    Pastan IH
    Cancer Detect Prev; 1993; 17(2):289-93. PubMed ID: 8402714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudomonas exotoxin--immunotoxins.
    FitzGerald DJ; Willingham MC; Pastan I
    Cancer Treat Res; 1988; 37():161-73. PubMed ID: 2908624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted therapy with immunotoxins in a nude rat model for leptomeningeal growth of human small cell lung cancer.
    Myklebust AT; Godal A; Fodstad O
    Cancer Res; 1994 Apr; 54(8):2146-50. PubMed ID: 8174121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved antitumor activity of a recombinant anti-Lewis(y) immunotoxin not requiring proteolytic activation.
    Kuan CT; Pastan I
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):974-8. PubMed ID: 8577771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo.
    Azemar M; Schmidt M; Arlt F; Kennel P; Brandt B; Papadimitriou A; Groner B; Wels W
    Int J Cancer; 2000 Apr; 86(2):269-75. PubMed ID: 10738256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of immunotoxins using Pseudomonas exotoxin A.
    FitzGerald DJ
    Methods Enzymol; 1987; 151():139-45. PubMed ID: 3123880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoimmunotoxin therapy against a human colon tumor (HT-29) xenografted into nude mice.
    Pearson JW; FitzGerald DJ; Willingham MC; Wiltrout RH; Pastan I; Longo DL
    Cancer Res; 1989 Jul; 49(13):3562-7. PubMed ID: 2499420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced therapeutic efficacy of an immunotoxin in combination with chemotherapy against an intraperitoneal human tumor xenograft in athymic mice.
    Pearson JW; Sivam G; Manger R; Wiltrout RH; Morgan AC; Longo DL
    Cancer Res; 1989 Sep; 49(18):4990-5. PubMed ID: 2504482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor effect of an HER2-specific antibody-toxin fusion protein on human prostate cancer cells.
    Wang L; Liu B; Schmidt M; Lu Y; Wels W; Fan Z
    Prostate; 2001 Apr; 47(1):21-8. PubMed ID: 11304726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudomonas Exotoxin A Based Toxins Targeting Epidermal Growth Factor Receptor for the Treatment of Prostate Cancer.
    Fischer A; Wolf I; Fuchs H; Masilamani AP; Wolf P
    Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33260619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of immunotoxins active against ovarian cancer cell lines.
    Pirker R; FitzGerald DJ; Hamilton TC; Ozols RF; Laird W; Frankel AE; Willingham MC; Pastan I
    J Clin Invest; 1985 Sep; 76(3):1261-7. PubMed ID: 3930572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel anti-CD30 recombinant immunotoxins containing disulfide-stabilized Fv fragments.
    Nagata S; Onda M; Numata Y; Santora K; Beers R; Kreitman RJ; Pastan I
    Clin Cancer Res; 2002 Jul; 8(7):2345-55. PubMed ID: 12114439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoconjugates of Pseudomonas exotoxin A: evaluation in mice, monkeys, and man.
    Morgan AC; Manger R; Pearson JW; Longo D; Abrams P; Sivam G; Bjorn M
    Cancer Detect Prev; 1991; 15(2):137-43. PubMed ID: 2032255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of Diphtheria and Pseudomonas Exotoxin A Immunotoxins and Evaluation of Their Cytotoxicity Effect on SK-BR-3, BT-474, and MDA-MB-231 Breast Cancer Cell Lines.
    Amoozadeh S; Hemmati M; Farajollahi MM; Akbari N; Tarighi P
    Cancer Invest; 2019; 37(10):546-557. PubMed ID: 31597492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-PSMA immunotoxin as novel treatment for prostate cancer? High and specific antitumor activity on human prostate xenograft tumors in SCID mice.
    Wolf P; Alt K; Bühler P; Katzenwadel A; Wetterauer U; Tacke M; Elsässer-Beile U
    Prostate; 2008 Feb; 68(2):129-38. PubMed ID: 18044731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant single-chain immunotoxins against T and B cell leukemias.
    Kreitman RJ; Pastan I
    Leuk Lymphoma; 1994 Mar; 13(1-2):1-10. PubMed ID: 8025511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of VEGFR2-specific Nanobody Pseudomonas exotoxin A conjugated to provide efficient inhibition of tumor cell growth.
    Behdani M; Zeinali S; Karimipour M; Khanahmad H; Schoonooghe S; Aslemarz A; Seyed N; Moazami-Godarzi R; Baniahmad F; Habibi-Anbouhi M; Hassanzadeh-Ghassabeh G; Muyldermans S
    N Biotechnol; 2013 Jan; 30(2):205-9. PubMed ID: 23031816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin.
    Batra JK; Jinno Y; Chaudhary VK; Kondo T; Willingham MC; FitzGerald DJ; Pastan I
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8545-9. PubMed ID: 2510169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of an immunotoxin to folate receptor beta on bleomycin-induced experimental pulmonary fibrosis.
    Nagai T; Tanaka M; Hasui K; Shirahama H; Kitajima S; Yonezawa S; Xu B; Matsuyama T
    Clin Exp Immunol; 2010 Aug; 161(2):348-56. PubMed ID: 20550546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.